Loading candles…
Infinium Pharmachem Ltd was incorporated in 2003 and specializes in the manufacture and sale of iodine-based pharmaceutical intermediates and chemical compounds. Its product portfolio includes complex iodine derivatives and active pharmaceutical ingredients (APIs) catering to industries such as pharmaceuticals, agrochemicals, electronics, and specialty chemicals. The company is recognized as a key participant in the niche iodine chemistry market and leverages its research and development capabilities to support its operations. No information is provided on the company's headquarters, founders, key management, subsidiaries, notable projects, geographies of operation, or stock exchange listings.
This page is a live market overview for INFINIUM PHARMACHEM LTD (INFINIUM) on the NSE. As a listed security, INFINIUM PHARMACHEM LTD is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for INFINIUM before placing trades on tick2trade.
As of the latest feed, INFINIUM last traded at ₹219.5 on NSE, up ₹9.55 (4.55%) from the previous close of ₹209.95. Today's session range is ₹212 – ₹220, against a 52-week band of ₹189.4 – ₹276. Traded volume today stands at 7.00K shares.
The overview consolidates an interactive price chart with multiple time ranges, upcoming corporate events for INFINIUM in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether INFINIUM is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for INFINIUM PHARMACHEM LTD before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in INFINIUM. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated INFINIUM option chain page linked from this overview.
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.